- Home
- MTEN vs VRAX Comparison
MTEN vs VRAX Comparison
Compare MTEN & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTEN | VRAX |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | China | United Kingdom |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.7M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MTEN | VRAX |
|---|---|---|
| Price | $1.04 | $0.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 28.5K | ★ 2.7M |
| Earning Date | 05-21-2026 | 06-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $217,274.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.02 | $0.10 |
| 52 Week High | $26.03 | $1.18 |
Technical Indicators
Market Signals| Indicator | MTEN | VRAX |
|---|---|---|
| Relative Strength Index (RSI) | 35.05 | 44.56 |
| Support Level | $0.90 | $0.12 |
| Resistance Level | $1.35 | $0.18 |
| Average True Range (ATR) | 0.09 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 45.51 | 16.33 |
Price Performance
Historical ComparisonAbout MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.